Michael Ryskin

Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2 <i>H</i> )-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors

Pei‐Pei Kung, Eugene Rui, Simon Bergqvist et al. · Journal of Medicinal Chemistry · 2016 · 68 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2

Stephen G. Dann, Michael Ryskin, Anthony M. Barsotti et al. · The EMBO Journal · 2015 · 61 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth

Anthony M. Barsotti, Michael Ryskin, Wenyan Zhong et al. · Oncotarget · 2015 · 46 citations · Full text

Life Sciences, Genetics, Oncology +16

Indications for cone biopsy: Pathologic correlation

Mark Spitzer, A E Chernys, Alexander L. Shifrin et al. · American Journal of Obstetrics and Gynecology · 1998 · 29 citations

Medicine, Pathology, Anatomic Pathology +12

The Value of Repeat Pap Smear at the Time of Initial Colposcopy

Mark Spitzer, Michael Ryskin, A E Chernys et al. · Gynecologic Oncology · 1997 · 27 citations

Medicine, Gynecology, Pathology +14